← Open Payments lookup

ANNA HESSE: Open Payments

NPI 1770368524 · NEW BRITAIN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,200 in 81 payments from 18 companies in 2025. Trend: 2023 $23 · 2024 $3,049 · 2025 $2,200

Food & beverage: $2,101Education: $99
CompanyPaymentsAmount
Alnylam Pharmaceuticals Inc.7$337
Actelion Pharmaceuticals US, Inc.7$267
Amgen Inc.10$251
PFIZER INC.12$240
Novo Nordisk Inc4$192
Novartis Pharmaceuticals Corporation8$186
Bayer Healthcare Pharmaceuticals Inc.4$123
SCPHARMACEUTICALS INC.7$112
Merck Sharp & Dohme LLC4$98
Lilly USA, LLC3$77

Products named: Repatha, OPSUMIT, ELIQUIS, LEQVIO, Kerendia, Ozempic, AMVUTTRA, FUROSCIX.

Industry payments across CT — which companies pay providers there.